Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: NIOSH Education and Research Center, Program Announcement Number (PAR) 06-485, 17555-17556 [E7-6591]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices
Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6582 Filed 4–6–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6588 Filed 4–6–07; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
17555
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6589 Filed 4–6–07; 8:45 am]
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Pre-Knowledge
of Early Hearing Detection and
Intervention Program Process and Its
Effect on Maternal Stress and
Compliance With Follow-Up, Potential
Extramural Project (PEP) 2007–R–07
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–4 p.m., May 16,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of PEP 2007–R–07, ‘‘PreKnowledge of Early Hearing Detection and
Intervention Program Process and Its Effect
on Maternal Stress and Compliance with
Follow-Up.’’
For Further Information Contact: Juliana
Cyril, M.P.H., Ph.D., Associate Director for
Policy and Peer Review, CDC, 1600 Clinton
Road, NE., Mailstop D72, Atlanta, GA 30333,
telephone 404–639–4639.
The Director, Management Analysis and
Services Office, has been delegated the
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP):
Epidemiological Studies of Epilepsy,
Potential Extramural Project (PEP)
2007–R–05
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned SEP.
Time and Date: 12 p.m.–4 p.m., May 10,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of scientific merit of applications
for ‘‘Epidemiological Studies of Epilepsy,’’
PEP 2007–R–05.
For Further Information Contact: Juliana
Cyril, M.P.H., Ph.D., Associate Director for
Policy and Peer Review, CDC, 1600 Clifton
Road, NE., Mailstop D–72, Atlanta, GA
30333, Telephone (404) 639–3098.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: NIOSH Education and
Research Center, Program
Announcement Number (PAR) 06–485
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Meeting of the
aforementioned Special Emphasis
Panel:
Time and Date: 10 a.m.–1 p.m., April 24,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Purpose: The work groups which were
convened at specific sites listed below
advised and made recommendations to the
Disease, Disability, and Injury Prevention
and Control SEP: NIOSH Education and
Research Center, PAR 06–485. Specifically,
the SEP makes recommendations regarding
policies, strategies, and funding.
TIMES, DATES, AND PLACES OF THE WORK GROUP MEETINGS
November 13, 2006 (Closed) ................
8 a.m.–5 p.m. ..........
November 28, 2006 (Closed) ................
8
8
8
8
8
sroberts on PROD1PC70 with NOTICES
8 a.m.–5 p.m. ..........
December 11, 2006 (Closed) ................
December 14, 2006 (Closed) ................
January 9, 2007 (Closed) ......................
January 16, 2007 (Closed) ....................
February 13, 2007 (Closed) ..................
a.m.–5
a.m.–5
a.m.–5
a.m.–5
a.m.–5
p.m.
p.m.
p.m.
p.m.
p.m.
..........
..........
..........
..........
..........
Matters to be Discussed: The SEP meeting
will include the review, discussion, and
evaluation of research grant applications in
response to ‘‘NIOSH Education and Research
Center,’’ PAR 06–485.
VerDate Aug<31>2005
18:21 Apr 06, 2007
Jkt 211001
Women’s Faculty Club on the University of California Berkeley campus 510–
642–4175.
University of Alabama at Birmingham, Administration Building Penthouse, 701
20th Street South, 14th floor, Conference Room 1, 205–934–0771.
Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD 21205.
College of Public Health 13201 Bruce B. Downs Blvd Tampa, FL 33612.
Fitzsimons Campus, Nighthorse Campbell Building. Room 304 Denver, CO.
Coffman Memorial Union 300 Washington Ave. SE Minneapolis, MN 55455.
University Park Marriott 480 Wakara Way Salt Lake City, UT 84108 801–584–
3312.
For Further Information Contact: Dr.
Charles N. Rafferty, Ph.D., B.S., Scientific
Review Administrator, 1600 Clifton Road NE,
MS E74, Atlanta, GA, 30333, telephone
404.498.2582.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
E:\FR\FM\09APN1.SGM
09APN1
17556
Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 3, 2007.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6591 Filed 4–6–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry; The Board of
Scientific Counselors (BSC), Centers
for Disease Control and Prevention
(CDC), National Center for
Environmental Health (NCEH)/Agency
for Toxic Substances and Disease
Registry (ATSDR): Meeting
sroberts on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of the
Federal Advisory Committee Act (Pub. L. 92–
463), CDC and ATSDR announce the
following meeting of the aforementioned
committee:
Times and Dates: 8 a.m.–4:45 p.m.,
May 17, 2007. 8 a.m.–12 p.m., May 18,
2007.
Place: 1825 Century Boulevard,
Atlanta, Georgia 30345.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: The Secretary, Department
of Health and Human Services (HHS),
and by delegation, the Director, CDC,
are authorized under Section 301 (42
U.S.C. 241) and Section 311 (42 U.S.C.
243) of the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and well being; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC, and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
VerDate Aug<31>2005
18:21 Apr 06, 2007
Jkt 211001
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters To Be Discussed: An update
on NCEH/ATSDR’s Office of the
Director; an update on Science and
Public Health and Reports; an update on
the Health Department Subcommittee,
the Community and Tribal
Subcommittee, and the Program Peer
Review Subcommittee (PPRS) Reports
and Discussion; a presentation on CDC’s
Web site redesign and the NCEH/
ATSDR Web site; an update on Climate
Change Initiative; a presentation on the
Office of Tribal Affairs’ Expert Panel
Report; an update on issues from the
Board; a discussion on the Office of
Management and Budget Performance
Assessment and Review Techniques
goals and objectives; an update on the
National Exposure Report; an update on
Preparedness and Emergency Response
priorities and portfolio; and a
discussion on BSC—PPRS Draft Peer
Review Report on ATSDR Site-Specific
Activities.
Agenda items are tentative and
subject to change.
FOR FURTHER INFORMATION CONTACT:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
1600 Clifton Road, Mail Stop E–28,
Atlanta, Georgia 30303; telephone 404/
498–0003, fax 404/498–0622; E-mail:
smalcom@cdc.gov. The deadline for
notification of attendance is May 4,
2007.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
NCEH/ATSDR.
Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6585 Filed 4–6–07; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 1978N–0224 (formerly Docket
No. 78N–0224); DESI 11853]
Trimethobenzamide Hydrochloride
Suppositories; Withdrawal of Approval
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
resolution of issues concerning
trimethobenzamide hydrochloride
suppositories. This notice announces
the withdrawal of approval of the new
drug application (NDA) for Tigan
(trimethobenzamide hydrochloride)
Suppositories. The notice also declares
that the marketing of unapproved
trimethobenzamide hydrochloride
suppository products is unlawful and
subject to FDA regulatory action. FDA is
taking these actions because
trimethobenzamide hydrochloride
suppositories lack substantial evidence
of effectiveness.
ADDRESSES: Requests for an opinion on
the applicability of this notice to a
specific trimethobenzamide
hydrochloride suppository product
should be identified with Docket No.
1978N–0224 and reference number DESI
11853 and directed to the Office of
Compliance, Division of New Drugs and
Labeling Compliance (HFD–310), New
Drugs and Labeling Team, Center for
Drug Evaluation and Research, Food
and Drug Administration, 11919
Rockville Pike, Rockville, MD 20852.
DATE: Effective May 9, 2007.
FOR FURTHER INFORMATION CONTACT:
Brian L. Pendleton, Center for Drug
Evaluation and Research (HFD–7), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–594–
2041.
SUPPLEMENTARY INFORMATION:
I. Background
As part of its Drug Efficacy Study
Implementation (DESI) program, in a
notice published in the Federal Register
on February 24, 1971 (36 FR 3435) (the
1971 notice), FDA announced the
following conclusions regarding certain
drug products that contain
trimethobenzamide hydrochloride: (1)
The products were probably effective for
nausea and vomiting due to radiation
therapy or travel sickness and for emesis
associated with operative procedures,
labyrinthitis, or Meniere’s syndrome; (2)
they were lacking substantial evidence
E:\FR\FM\09APN1.SGM
09APN1
]]>Agencies
[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Pages 17555-17556]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6591]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: NIOSH Education and Research Center, Program
Announcement Number (PAR) 06-485
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Meeting of the aforementioned
Special Emphasis Panel:
Time and Date: 10 a.m.-1 p.m., April 24, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Purpose: The work groups which were convened at specific sites
listed below advised and made recommendations to the Disease,
Disability, and Injury Prevention and Control SEP: NIOSH Education
and Research Center, PAR 06-485. Specifically, the SEP makes
recommendations regarding policies, strategies, and funding.
Times, Dates, and Places of the Work Group Meetings
------------------------------------------------------------------------
------------------------------------------------------------------------
8 a.m.-5 p.m.................. November 13, 2006 Women's Faculty Club
(Closed). on the University of
California Berkeley
campus 510-642-4175.
8 a.m.-5 p.m.................. November 28, 2006 University of Alabama
(Closed). at Birmingham,
Administration
Building Penthouse,
701 20th Street
South, 14th floor,
Conference Room 1,
205-934-0771.
8 a.m.-5 p.m.................. December 11, 2006 Bloomberg School of
(Closed). Public Health, 615
N. Wolfe St,
Baltimore, MD 21205.
8 a.m.-5 p.m.................. December 14, 2006 College of Public
(Closed). Health 13201 Bruce
B. Downs Blvd Tampa,
FL 33612.
8 a.m.-5 p.m.................. January 9, 2007 Fitzsimons Campus,
(Closed). Nighthorse Campbell
Building. Room 304
Denver, CO.
8 a.m.-5 p.m.................. January 16, 2007 Coffman Memorial
(Closed). Union 300 Washington
Ave. SE Minneapolis,
MN 55455.
8 a.m.-5 p.m.................. February 13, 2007 University Park
(Closed). Marriott 480 Wakara
Way Salt Lake City,
UT 84108 801-584-
3312.
------------------------------------------------------------------------
Matters to be Discussed: The SEP meeting will include the
review, discussion, and evaluation of research grant applications in
response to ``NIOSH Education and Research Center,'' PAR 06-485.
For Further Information Contact: Dr. Charles N. Rafferty, Ph.D.,
B.S., Scientific Review Administrator, 1600 Clifton Road NE, MS E74,
Atlanta, GA, 30333, telephone 404.498.2582.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for
[[Page 17556]]
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 3, 2007.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-6591 Filed 4-6-07; 8:45 am]
BILLING CODE 4163-18-P
